245 related articles for article (PubMed ID: 32881478)
61. Primary Amebic Meningoencephalitis Associated With Rafting on an Artificial Whitewater River: Case Report and Environmental Investigation.
Cope JR; Murphy J; Kahler A; Gorbett DG; Ali I; Taylor B; Corbitt L; Roy S; Lee N; Roellig D; Brewer S; Hill VR
Clin Infect Dis; 2018 Feb; 66(4):548-553. PubMed ID: 29401275
[TBL] [Abstract][Full Text] [Related]
62. Amphotericin B induces apoptosis-like programmed cell death in Naegleria fowleri and Naegleria gruberi.
Cárdenas-Zúñiga R; Silva-Olivares A; Villalba-Magdaleno JA; Sánchez-Monroy V; Serrano-Luna J; Shibayama M
Microbiology (Reading); 2017 Jul; 163(7):940-949. PubMed ID: 28721850
[TBL] [Abstract][Full Text] [Related]
63. Primary Amoebic Meningoencephalitis: Neurochemotaxis and Neurotropic Preferences of Naegleria fowleri.
Baig AM
ACS Chem Neurosci; 2016 Aug; 7(8):1026-9. PubMed ID: 27447543
[TBL] [Abstract][Full Text] [Related]
64. Fatal primary meningoencephalitis caused by Naegleria fowleri.
Shariq A; Afridi FI; Farooqi BJ; Ahmed S; Hussain A
J Coll Physicians Surg Pak; 2014 Jul; 24(7):523-5. PubMed ID: 25052979
[TBL] [Abstract][Full Text] [Related]
65. Nitric oxide production and nitric oxide synthase immunoreactivity in Naegleria fowleri.
Rojas-Hernández S; Rodríguez-Monroy MA; Moreno-Fierros L; Jarillo-Luna A; Carrasco-Yepez M; Miliar-García A; Campos-Rodríguez R
Parasitol Res; 2007 Jul; 101(2):269-74. PubMed ID: 17340143
[TBL] [Abstract][Full Text] [Related]
66. Therapeutic effect of rokitamycin in vitro and on experimental meningoencephalitis due to Naegleria fowleri.
Kim JH; Lee YJ; Sohn HJ; Song KJ; Kwon D; Kwon MH; Im KI; Shin HJ
Int J Antimicrob Agents; 2008 Nov; 32(5):411-7. PubMed ID: 18762406
[TBL] [Abstract][Full Text] [Related]
67. Fatal case of Naegleria fowleri meningo-encephalitis in an infant: case report.
Hebbar S; Bairy I; Bhaskaranand N; Upadhyaya S; Sarma MS; Shetty AK
Ann Trop Paediatr; 2005 Sep; 25(3):223-6. PubMed ID: 16156990
[TBL] [Abstract][Full Text] [Related]
68. Studies on the cyst stage of Naegleria fowleri in vivo and in vitro.
Evdokiou A; Marciano-Cabral F; Jamerson M
J Eukaryot Microbiol; 2022 Mar; 69(2):e12881. PubMed ID: 34918439
[TBL] [Abstract][Full Text] [Related]
69. Primary amebic meningoencephalitis: a review of the clinical literature.
Hannisch W; Hallagan LF
Wilderness Environ Med; 1997 Nov; 8(4):211-3. PubMed ID: 11990164
[TBL] [Abstract][Full Text] [Related]
70. Laurinterol from Laurencia johnstonii eliminates Naegleria fowleri triggering PCD by inhibition of ATPases.
Arberas-Jiménez I; García-Davis S; Rizo-Liendo A; Sifaoui I; Reyes-Batlle M; Chiboub O; Rodríguez-Expósito RL; Díaz-Marrero AR; Piñero JE; Fernández JJ; Lorenzo-Morales J
Sci Rep; 2020 Oct; 10(1):17731. PubMed ID: 33082417
[TBL] [Abstract][Full Text] [Related]
71. Primary amebic meningoencephalitis deaths associated with sinus irrigation using contaminated tap water.
Yoder JS; Straif-Bourgeois S; Roy SL; Moore TA; Visvesvara GS; Ratard RC; Hill VR; Wilson JD; Linscott AJ; Crager R; Kozak NA; Sriram R; Narayanan J; Mull B; Kahler AM; Schneeberger C; da Silva AJ; Poudel M; Baumgarten KL; Xiao L; Beach MJ
Clin Infect Dis; 2012 Nov; 55(9):e79-85. PubMed ID: 22919000
[TBL] [Abstract][Full Text] [Related]
72. Repurposing in vitro approaches for screening anti-parasitic drugs against the brain-eating amoeba Naegleria fowleri.
Martín-Escolano R; Yiangou L; Kazana E; Robinson GK; Michaelis M; Tsaousis AD
Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():204-212. PubMed ID: 34875573
[TBL] [Abstract][Full Text] [Related]
73. Naegleria fowleri: differential genetic expression following treatment with Hesperidin conjugated with silver nanoparticles using RNA-Seq.
Siddiqui R; Rajendran K; Abdella B; Ayub Q; Lim SY; Khan NA
Parasitol Res; 2020 Jul; 119(7):2351-2358. PubMed ID: 32451717
[TBL] [Abstract][Full Text] [Related]
74. Primary amoebic meningoencephalitis due to Naegleria fowleri.
Kaushal V; Chhina DK; Ram S; Singh G; Kaushal RK; Kumar R
J Assoc Physicians India; 2008 Jun; 56():459-62. PubMed ID: 18822627
[TBL] [Abstract][Full Text] [Related]
75. Seasonal primary amebic meningoencephalitis (PAM) in the south: summertime is PAM time.
Diaz J
J La State Med Soc; 2012; 164(3):148-50, 152-5. PubMed ID: 22866356
[TBL] [Abstract][Full Text] [Related]
76. Diagnosis of the primary amoebic meningoencephalitis due to Naegleria fowleri.
Hara T; Fukuma T
Parasitol Int; 2005 Dec; 54(4):219-21. PubMed ID: 16002330
[TBL] [Abstract][Full Text] [Related]
77. Protective immunity against Naegleria fowleri infection on mice immunized with the rNfa1 protein using mucosal adjuvants.
Lee J; Yoo JK; Sohn HJ; Kang HK; Kim D; Shin HJ; Kim JH
Parasitol Res; 2015 Apr; 114(4):1377-85. PubMed ID: 25604672
[TBL] [Abstract][Full Text] [Related]
78. [Amebic meningoencephalitis].
Fukuma T
Brain Nerve; 2009 Feb; 61(2):115-21. PubMed ID: 19235460
[TBL] [Abstract][Full Text] [Related]
79. Case Series of
Ghanchi NK; Jamil B; Khan E; Ansar Z; Samreen A; Zafar A; Hasan Z
Am J Trop Med Hyg; 2017 Nov; 97(5):1600-1602. PubMed ID: 29016297
[No Abstract] [Full Text] [Related]
80. Identification of peptidases in highly pathogenic vs. weakly pathogenic Naegleria fowleri amebae.
Vyas IK; Jamerson M; Cabral GA; Marciano-Cabral F
J Eukaryot Microbiol; 2015; 62(1):51-9. PubMed ID: 25066578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
